Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Real Time RT-PCR02:57

Real Time RT-PCR

56.9K
Real-time reverse transcription-polymerase chain reaction, or Real-time RT-PCR, is an analytical tool used to determine the expression level of target genes. The method involves converting mRNA to complementary DNA with the help of an enzyme known as reverse transcriptase, followed by the PCR amplification of the cDNA. These two processes can be performed simultaneously in a single tube or separately as a two-step reaction.
The real-time quantification of the number of amplified products is...
56.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproducibility Assessment of the Crystal Violet Biofilm Assay in Clostridioides difficile.

Anaerobe·2026
Same author

Recovery and Stability of Omadacycline 150-mg Crushed Tablets Dispersed in Food or Water and Administered via Nasogastric Tube.

Open forum infectious diseases·2026
Same author

Candidiasis epidemiology and outcomes including emergence of <i>Candida auris</i> from a large, Southern US metro area: a six-year evaluation.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2025
Same author

A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile Risk.

The Journal of infectious diseases·2025
Same author

Prebiotics Improve Blood Pressure Control by Modulating Gut Microbiome Composition and Function: A Systematic Review and Meta-Analysis.

Nutrients·2025
Same author

Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial.

The Journal of antimicrobial chemotherapy·2025

Related Experiment Video

Updated: Jun 5, 2025

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples
08:00

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples

Published on: October 18, 2019

19.9K

A quantitative PCR to detect non-toxigenic Clostridioides difficile.

Khurshida Begum1, Hubert C Chua1, M Jahangir Alam1

  • 1Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA.

Microbiology Spectrum
|December 11, 2024
PubMed
Summary

A new qPCR assay can detect non-toxigenic Clostridioides difficile (NTCD) strains, which may protect against C. difficile infection (CDI). This assay identified NTCD colonization in 7% of hospitalized patients, aiding diagnostics and antimicrobial stewardship.

Keywords:
Clostridioides difficilediagnosticsnon-toxigenicstewardship

More Related Videos

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

8.9K
Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

12.9K

Related Experiment Videos

Last Updated: Jun 5, 2025

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples
08:00

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples

Published on: October 18, 2019

19.9K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

8.9K
Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

12.9K

Area of Science:

  • Microbiology
  • Molecular Diagnostics
  • Infectious Diseases

Background:

  • Current diagnostics for Clostridioides difficile infection (CDI) do not identify non-toxigenic C. difficile (NTCD) strains.
  • NTCD colonization may confer protection against CDI, but its prevalence is unknown due to diagnostic limitations.

Purpose of the Study:

  • To develop and validate a molecular assay for the specific detection of NTCD.
  • To assess the prevalence of NTCD colonization in hospitalized patients undergoing testing for CDI.

Main Methods:

  • A quantitative PCR (qPCR) assay was designed using specific primers and probes targeting unique regions of NTCD.
  • The assay's analytical sensitivity and specificity were validated using reference strains.
  • 95 clinical stool samples were analyzed to determine NTCD prevalence in patients tested for CDI.

Main Results:

  • The developed qPCR assay demonstrated high analytical sensitivity (linear between 3x10^1 and 3x10^6 gDNA, R^2=0.999).
  • NTCD was detected in 20% of samples negative for GDH enzyme and 8.7% of samples positive for GDH enzyme.
  • The assay identified NTCD colonization in 7% of the overall hospitalized patient cohort.

Conclusions:

  • A novel qPCR assay effectively identifies NTCD strains, enabling their detection in clinical samples.
  • NTCD colonization is present in a notable percentage of hospitalized patients, suggesting a potential protective role against CDI.
  • This assay has significant implications for improving CDI diagnostics, infection control, and antimicrobial stewardship strategies.